Balance Training for Chronic Obstructive Pulmonary Disease (COPD)
- Conditions
- Chronic Obstructive Pulmonary Disease
- Interventions
- Other: Balance training
- Registration Number
- NCT02080442
- Lead Sponsor
- Samantha Harrison
- Brief Summary
The study will involve direct knowledge translation of a laboratory-based study of balance training for patients with COPD, first to the investigators PR program and then, after disseminating the results, this approach could be used to impact on clinical practice in any PR program.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 19
- Diagnosis of COPD
- Self-report of decline in balance or fall in the last 5 years or a recent near fall
- Smoking history greater than 10 pack years
- Are able to provide written informed consent.
- An inability to communicate because of language skills, hearing or cognitive impairment
- Evidence of a neurological or musculoskeletal condition that severely limits mobility and postural control (e.g., cerebrovascular accident, advanced Parkinson's disease, amputation).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Chronic Obstructive Pulmonary Disease Balance training -
- Primary Outcome Measures
Name Time Method Berg Balance Scale (BBS) at 6 weeks The BBS was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.
Timed Up and Go (TUG): at 6 weeks The TUG was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.
- Secondary Outcome Measures
Name Time Method The Balance Evaluation Systems Test (BESTest) at 6 weeks The BESTest was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.
Activity-specific Balance Confidence (ABC) Scale at 6 weeks The ABC scale was assessed following completion of the balance training which took place thrice weekly for a period of 6 weeks.
Trial Locations
- Locations (1)
West Park Healthcare Center
🇨🇦Toronto, Ontario, Canada